<prompt> Treatment of Behcets syndrome consists of:AVincristineBAspirinCGlucocorticoidsDThalidomideABCBCDCADBCA  <response>: The severity of the syndrome usually abates with time. Apart from the patients with CNS-Behcets syndrome and major vessel disease, the life expectancy seems to be normal, and the only seriouscomplication is blindness. Mucous membrane involvement may respond to topical glucocorticoids in the form of mouthwash or paste. In more serious cases, thalidomide 100 mgd is effective. Thrombophlebitis is treated withaspirin, 32 5 mgd. Colchicine can be beneficial for the mucocutaneous manifestations of the syndrome.Uveitis and CNS-Behcets syndrome require systemic glucocorticoid therapy prednisone, 1mgkgperdav and azathioprine, 2-3 mgkg per day. Interferon has proved to be very effective not only for CNS-Behcets syndrome but also for refractory uveitis.Topical agent used in Behcets syndrome: Steroids, tacrolimus local anesthetics- Neena Khanna 3rd204Chlorambucil, pentoxifylline cyclosporine are also used in Behcets syndrome-CMDT 06851 INTERNETAnti-TNF therapy such as infliximab has shown promise in treating the uveitis associated with the disease. Another Anti-TNF agent, Etanercept. may be useful in patients with mainly skin andmucosal symptoms.Interferon alfa-2a may also be an effective alternative treatment, particularly for the genital and oral ulcersDapsone and rebamipide have been shown, in small studies, to have beneficial results for mucocutaneous lesions.Given its rarity, the optimal treatment for acute optic neuropathy in Behcets disease has not been established. Early identification and treatment is essential. Response to ciclosporin.perioculartriamcinolone and IV methylprednisone followed by oral prednisone has been reported although relapsesleading to irreversible visual loss may occur even with treatment. 